Home Mapping the Blueprint of a 100-Billion-Yuan ART Market: Insight and Product Overview from Veebaio and VB100

Mapping the Blueprint of a 100-Billion-Yuan ART Market: Insight and Product Overview from Veebaio and VB100

Mar 18, 2021 16:14 CST Updated 16:14
The World Health Organization predicts that infertility will be ranked as one of the three major diseases affecting humanity in the 21st century, second only to cancer and cardiovascular and cerebrovascular diseases. As the population suffering from infertility rapidly expands, assisted reproductive technology (ART) has become one of the fastest-growing potential markets in China’s medical services industry. Although market size remains in a phase of potential accumulation due to policy constraints and socio-ethical limitations, the downstream segment of the industry chain is poised to open up amid explosive growth in market demand and the gradual decentralization of institutional approval authority. The industry is on the verge of rapid scale-up.


Against this backdrop,VCBeatCombinedVeto Bio, onAfternoon of April 17, 2021, jointly organized byThe 5th Future Healthcare Top 100 Conference · Assisted Reproductive Technology Industry Development Forum, covering enterprises across the upstream and downstream of the assisted reproductive technology industry, inviting leaders from government regulatory bodies, renowned entrepreneurs, and seasoned investors to focus onRegulatory Policies for Assisted Reproductive Technology, Domestic Production of Upstream Medical Devices, Brand Effects of Institutions, New Business Models in Internet Healthcare, and Market Development Opportunities...and other current hot topics in the industry, jointly exploring the global landscape, policy and regulation, industry development, and investment trends.


At the conference venue, will be releasedCurrent Status and Trends of the Assisted Reproductive Technology Industry & "2021 Assisted Reproductive Technology Industry Research Report", VCBeat will through1,000 User SurveysandCase Studies of Over 10 Companies, anchoring to the real-world demands of assisted reproductive technology (ART), reviewing the current state of the industry, conducting an in-depth analysis of innovation pathways and models within the ART sector, pursuing maximization of service value, and identifying new drivers for growth in assisted reproduction.


>>>

Partially Confirmed Guests


论坛议程_03.png

Arranged by Guest Speaker Order


>>>>

Forum Agenda

论坛议程_02.png


>>>>

About WeiTuo Bio


Vitrolife was established in 2015 as a national high-tech enterprise. It is an upstream technology and product supplier in the field of assisted reproduction, dedicated to providing cutting-edge technologies for assisted reproduction and offering integrated solutions for assisted reproduction laboratories worldwide. Its products are sold to major regions across the globe, including Europe, the Americas, and the Asia-Pacific.


The 5th Future Healthcare Top 100 Conference will, with“Calculating Life”as the theme, comprehensively showcase the innovative ecosystem of China’s healthcare sector and create a premier event for the integration of industrial ecosystems.


Conference Time:April 16–18, 2021 (Friday–Sunday), with the aim of minimizing concerns about work disruption

Venue:Suzhou · Wujiang

Organizer:VCBeat, VB100, VCBeat Institute, Artery Orange

Co-organized by:Wujiang District People's Government, Guangdong Zhong Nanshan Medical Foundation, China Clinical Research Consortium

Co-organizers:Suzhou Wujiang Oriental State-owned Capital Investment and Operation Co., Ltd., Smart and Mobile Healthcare Branch of China Medical Devices Industry Association, Internet Hospital Branch of China Research Hospital Association

Co-organizers of the Sub-forum:Yangtze River Delta Integration Demonstration Zone (Suzhou) Venture Capital Service Co., Ltd., Dolphin Internet Medical Industrial Park, UK Beyond Lab, China Digital Therapeutics Alliance (Preparatory), Medlink Consulting Co., Ltd. (China Medlink), UK Global Health Group, Yuanyi Capital, Chuangrui Investment, 5Y Capital, Weilai Capital, Mingfeng Capital, Harvard China Health Association, Early Screening Network, GeneInsight, Weituo Biotechnology, Bohou Medical


官网.png

 http://vb100.vcbeat.top/

Click the link or scan the QR code to view conference details and purchase tickets.


“Calculating Life”: The 5th Future Healthcare 100 Conference

April 16–18, 2021, VCBeat will join forces withPeople's Government of Wujiang District, Suzhou CityBroadGuangdong Zhong Nanshan Medical FoundationSuzhou Wujiang Oriental State-owned Capital Investment and Operation Co., Ltd.InSuzhou · WujiangCo-hosting the 5th Future Healthcare Top 100 Conference. The conference will focus on the healthcare industry, with attention to personal health, public health, the healthcare industry chain, and supporting systems. For the first time, it will explore the industrial ecosystem of the conference, link more possibilities in healthcare, and achieve a comprehensive upgrade of the Top 100 Conference.


>>>>

Partially Confirmed Guests


Zhang Zhiyuan | Academician of the Chinese Academy of Engineering

Shiqing Chen| Member of the U.S. National Academy of Engineering, Supercomputing Expert

Li Changming | Dean of the School of Materials Science and Engineering, Suzhou University of Science and Technology; Academician of Academia Europaea

Timothy Johns | Digital Health Officer, British Consulate-General in Shanghai

Song Yijun| Representative of the Government of Ontario, Canada; Commercial Counselor, Canadian Embassy in China

Sun Baoqing| Chairman of the Guangdong Zhong Nanshan Medical Foundation

Nick Rodgers| Chairman of the UK South East Medical Technology Alliance, Chairman of Destiny Pharma

Wang Tianmiao| Professor at Beihang University

Wang Jingjing| Executive Director, Tsinghua University Global Health Industry Innovation Center 

Jane Jin | Head of Oxford University's Technology Transfer Office, China Region

Zhi Zhang | Business Development Manager, Technology Department, UK Medical Research Council |

Chen Fangxia| Director of Business Development, Asia Technology Transfer Centre, Western University

Kimon Angelides | Founder, Livongo & Vivante

Luo Zhangwei| Chief Scientist, Suzhou Smart Healthcare Innovation Center; Former Chief AI Scientist, Siemens China Research Institute, Suzhou Branch

Liu Enmei| Deputy Director, Children's Hospital of Chongqing Medical University (Liangjiang Campus)

Chen Hongxiang| Executive Vice President, Union Shenzhen Hospital of Huazhong University of Science and Technology (Nanshan Hospital)

Tao Liang| President of Wuhan Asia Heart Hospital

Zhang Nuofu | Vice President of the First Affiliated Hospital of Guangzhou Medical University

Weng Jianping| Deputy Director of the Division of Life Sciences and Medicine, University of Science and Technology of China; President of Bengbu Medical College

Lei Juan| Deputy Director, West China Transfer Center, West China Hospital of Sichuan University

Wei Xuejie| Vice President of Xuzhou Mining Group General Hospital

Ye Xin| Deputy Dean of Yilianzhong Beijing Research Institute

Wu Xia| Managing Director, CICC Capital

Zhang Man| Vice President, China Renaissance

Wang Xiaohui| Managing Partner, Shengjing Jiacheng Fund of Funds

Hu Chuanwei| Vice President of Hengqin Financial Investment Group

Li Yuhui| Founding Managing Partner, Panlin Capital

Yu Zhengkun| Founding Partner of Jifeng Capital

Zhou Yi| Partner, Shenzhen Capital Group Health Industry Fund

Tian Min| Partner, Yuanjing Capital

Tang Haofu| Chairman of Chuangrui Investment

Ren Bobing| Executive Director of Sinovation Ventures

Andrew Craig| Partner, WG Fund

……


>>>>

Conference Highlights


Top-Tier Guest Lineup—Led by Academicians and IEEE Scientists200+Industry Leaders Present the Cutting-Edge in Medical Technology, Industry Trends, and Business Innovation Over Three Days

Business Wisdom of Industry Leaders——10Leading Listed Company Unveils Strategic Roadmap, Offering Insights into the Industry’s Future and Innovation Landscape

Global Perspective and Overseas Resources — FromUnited Kingdom, Israel, United States, Canada, Belgium, Germany, Denmark...and the industrial development trends and capital markets of multiple countries, linking high-quality overseas technological innovation projects

In-Depth Insights into Niche Sectors—Major Release10 copiesIndustry Research Series: Exploring Development Opportunities and Innovative Cases in Niche Sectors

Gathering the Core Forces of Future Healthcare — Release6 MajorTop 100 Rankings and Awards, Gathered1000+Unicorns and High-Potential Innovative Enterprises Jointly Explore Pathways for Innovation-Driven Development

Emphasizing the Translation of Scientific Research—Invitation10+Hospital Presidents, Research Experts, and University Professors: Breaking Boundaries to Explore the Integration of Industry and Research

A Forward-Looking Capital Perspective—100+Featuring forward-looking investors from GP, LP, CVC, VC, PE, FA, and other financial institutions to gauge the direction of capital heat in the industry

Harnessing the Momentum of the Industrial Ecosystem——10+Ecosystem Conference for Investment Firms and Industry Giants: Promoting Integration and Fission in the Industrial Ecosystem


>>>>

Conference Planning



版块结构_01.png


官网.png

 http://vb100.vcbeat.top/

Click the link or scan the QR code to view conference details and purchase tickets.